Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UK
- PMID: 40596845
- PMCID: PMC12211489
- DOI: 10.1186/s12874-025-02599-x
Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UK
Abstract
Background: Delivering research studies that require a large number of samples to monitor specific populations is complex, often resulting in high costs and intricate logistics. We aim to describe the processes for blood sample collection and management and evaluate alternative sampling methods within a large cohort of healthcare workers in the UK (the SIREN study).
Methods: We conducted a process evaluation. First, we described blood sample collection and management across different study periods from June 2020 to March 2024 and how these evolved over time. Secondly, we compared alternative methods of blood sampling: venous phlebotomy (hospital-based) vs. capillary sampling (at-home).
Results: The main challenges with blood sampling within SIREN stemmed from the scale and use of decentralised phlebotomy across 135 hospital sites during the COVID-19 pandemic. We adapted our sampling processes as the study progressed, overcoming most of these challenges. When comparing hospital-based and at-home sampling, overall, return rates of samples taken at home were higher than site- based samples (80% vs 71%, respectively). At-home samples took less time to be returned to UKHSA Laboratory for testing compared to hospital-based samples (median 2 days; interquartile (IQ) 2-3) vs 6 days; IQ 3-8). However, at-home samples were more likely to be considered void (4%) when tested compared to hospital-based samples (0%). Cost for hospital-based sampling was almost 3-times higher than at-home sampling (£34.05 vs £11.50, respectively), although larger sample volumes were obtained via hospital-based sampling when compared to at-home sampling (8 ml vs 600 µl of whole blood).
Conclusions: Sample collection and management in large scale research studies are complex. Our results support at-home blood sampling as an effective and cheaper strategy when compared to hospital-based phlebotomy and therefore should be considered as alternative sampling method for future research.
Trial registration number: ISRCTN11041050-registration date 12/01/2021.
Keywords: Blood specimen collection; Cohort studies; Evaluation; Phlebotomy.
© 2025. Crown.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study protocol was approved by the Berkshire Research Ethics Committee on May 22, 2020. Informed consent was obtained from all participants included in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Methods for blood loss estimation after vaginal birth.Cochrane Database Syst Rev. 2018 Sep 13;9(9):CD010980. doi: 10.1002/14651858.CD010980.pub2. Cochrane Database Syst Rev. 2018. PMID: 30211952 Free PMC article.
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Perceptions and experiences of the prevention, detection, and management of postpartum haemorrhage: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2023 Nov 27;11(11):CD013795. doi: 10.1002/14651858.CD013795.pub2. Cochrane Database Syst Rev. 2023. PMID: 38009552 Free PMC article.
References
-
- Vaughan A, Duffell E, Freidl GS, Lemos DS, Nardone A, Valenciano M, Subissi L, Bergeri I, K Broberg E, Penttinen P, Pebody R, Keramarou M. Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020. BMJ Open. 2023 Nov 6;13(11):e064240. 10.1136/bmjopen-2022-064240. PMID: 37931969; PMCID: PMC10632881. - PMC - PubMed
-
- Koulman A, Rennie KL, Parkington D, Tyrrell CS, Catt M, Gkrania-Klotsas E, Wareham NJ. The development, validation and application of remote blood sample collection in telehealth programmes. J Telemed Telecare. 2024 May;30(4):731–738. 10.1177/1357633X221093434. Epub 2022 May 10. PMID: 35538704; PMCID: PMC11027437. - PMC - PubMed
-
- Wong MP, Meas MA, Adams C, Hernandez S, Green V, Montoya M, Hirsch BM, Horton M, Quach HL, Quach DL, Shao X, Fedrigo I, Zermeno A, Huffaker J, Montes R, Madden A, Cyrus S, McDowell D, Williamson P, Contestable P, Stone M, Coloma J, Busch MP, Barcellos LF, Harris E. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies. Microbiol Spectr. 2022;10(3):e0247121. 10.1128/spectrum.02471-21. Epub 25 May 2022. PMID: 35612315; PMCID: PMC9241704. - PMC - PubMed
-
- Wixted D, Neighbors CE, Pieper CF, Wu A, Kingsbury C, Register H, Petzold E, Newby LK, Woods CW. Comparison of a Blood Self-Collection System with Routine Phlebotomy for SARS-CoV-2 Antibody Testing. Diagnostics (Basel). 2022;12(8):1857. 10.3390/diagnostics12081857. PMID: 36010206; PMCID: PMC9406345 . - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical